Stem Cells Therapy for Spinal Cord Injury
AbstractSpinal cord injury (SCI), a serious public health issue, most likely occurs in previously healthy young adults. Current therapeutic strategies for SCI includes surgical decompression and pharmacotherapy, however, there is still no gold standard for the treatment of this devastating condition. Inefficiency and adverse effects of standard therapy indicate that novel therapeutic strategies are required. Because of their neuroregenerative and neuroprotective properties, stem cells are a promising tool for the treatment of SCI. Herein, we summarize and discuss the promising therapeutic potential of human embryonic stem cells (hESC), induced pluripotent stem cells (iPSC) and ependymal stem/progenitor cells (epSPC) for SCI. View Full-Text
Share & Cite This Article
Gazdic, M.; Volarevic, V.; Harrell, C.R.; Fellabaum, C.; Jovicic, N.; Arsenijevic, N.; Stojkovic, M. Stem Cells Therapy for Spinal Cord Injury. Int. J. Mol. Sci. 2018, 19, 1039.
Gazdic M, Volarevic V, Harrell CR, Fellabaum C, Jovicic N, Arsenijevic N, Stojkovic M. Stem Cells Therapy for Spinal Cord Injury. International Journal of Molecular Sciences. 2018; 19(4):1039.Chicago/Turabian Style
Gazdic, Marina; Volarevic, Vladislav; Harrell, C. R.; Fellabaum, Crissy; Jovicic, Nemanja; Arsenijevic, Nebojsa; Stojkovic, Miodrag. 2018. "Stem Cells Therapy for Spinal Cord Injury." Int. J. Mol. Sci. 19, no. 4: 1039.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.